Global IBS-C Drugs Market Size, Status and Forecast 2022

October 2017 | 118 pages | ID: GFAAEAB0EF4PEN
QYResearch

Abstracts

This report studies the global IBS-C Drugs market, analyzes and researches the IBS-C Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Catalent Pharmaceuticals Solutions
• Nestle
• Abbott Laboratories
• Synergy Pharmaceuticals
• Sucampo Pharmaceuticals
• Novartis Pharma Ag
• Astellas Pharmaceuticals
• Ardelyx, Inc
• Synthetic Biologics, Inc
• Teva Pharmaceutical Industries
• Bama-Geve, SLU
• Ferring BV
• Ironwood Pharmaceuticals, Inc
• Salix Pharmaceuticals Ltd
• Norgine B.V
• Prometheus Laboratories Inc
• Actavis Nordic A/S
• Albireo Pharma Inc
• Yuhan Corp
• Astrazeneca Plc
• The Menarini Group
• Ono Pharmaceutical Co., Ltd

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, IBS-C Drugs can be split into

• Linaclotide
• Lubiprostone
• Osmotic Laxatives
• Stimulant Laxatives
• Other

Market segment by Application, IBS-C Drugs can be split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global IBS-C Drugs Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF IBS-C DRUGS

1.1 IBS-C Drugs Market Overview
  1.1.1 IBS-C Drugs Product Scope
  1.1.2 Market Status and Outlook
1.2 Global IBS-C Drugs Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 IBS-C Drugs Market by Type
  1.3.1 Linaclotide
  1.3.2 Lubiprostone
  1.3.3 Osmotic Laxatives
  1.3.4 Stimulant Laxatives
  1.3.5 Other
1.4 IBS-C Drugs Market by End Users/Application
  1.4.1 Hospital Pharmacies
  1.4.2 Retail Pharmacies
  1.4.3 Online Pharmacies

2 GLOBAL IBS-C DRUGS COMPETITION ANALYSIS BY PLAYERS

2.1 IBS-C Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Catalent Pharmaceuticals Solutions
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 IBS-C Drugs Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 Nestle
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 IBS-C Drugs Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 Abbott Laboratories
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 IBS-C Drugs Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Synergy Pharmaceuticals
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 IBS-C Drugs Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Sucampo Pharmaceuticals
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 IBS-C Drugs Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 Novartis Pharma Ag
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 IBS-C Drugs Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 Astellas Pharmaceuticals
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 IBS-C Drugs Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 Ardelyx, Inc
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 IBS-C Drugs Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 Synthetic Biologics, Inc
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 IBS-C Drugs Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 Teva Pharmaceutical Industries
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 IBS-C Drugs Revenue (Value) (2012-2017)
  3.10.5 Recent Developments
3.11 Bama-Geve, SLU
3.12 Ferring BV
3.13 Ironwood Pharmaceuticals, Inc
3.14 Salix Pharmaceuticals Ltd
3.15 Norgine B.V
3.16 Prometheus Laboratories Inc
3.17 Actavis Nordic A/S
3.18 Albireo Pharma Inc
3.19 Yuhan Corp
3.20 Astrazeneca Plc
3.21 The Menarini Group
3.22 Ono Pharmaceutical Co., Ltd

4 GLOBAL IBS-C DRUGS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global IBS-C Drugs Market Size by Type (2012-2017)
4.2 Global IBS-C Drugs Market Size by Application (2012-2017)
4.3 Potential Application of IBS-C Drugs in Future
4.4 Top Consumer/End Users of IBS-C Drugs

5 UNITED STATES IBS-C DRUGS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States IBS-C Drugs Market Size (2012-2017)
5.2 United States IBS-C Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU IBS-C DRUGS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU IBS-C Drugs Market Size (2012-2017)
6.2 EU IBS-C Drugs Market Size and Market Share by Players (2016 and 2017)

7 JAPAN IBS-C DRUGS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan IBS-C Drugs Market Size (2012-2017)
7.2 Japan IBS-C Drugs Market Size and Market Share by Players (2016 and 2017)

8 CHINA IBS-C DRUGS DEVELOPMENT STATUS AND OUTLOOK

8.1 China IBS-C Drugs Market Size (2012-2017)
8.2 China IBS-C Drugs Market Size and Market Share by Players (2016 and 2017)

9 INDIA IBS-C DRUGS DEVELOPMENT STATUS AND OUTLOOK

9.1 India IBS-C Drugs Market Size (2012-2017)
9.2 India IBS-C Drugs Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA IBS-C DRUGS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia IBS-C Drugs Market Size (2012-2017)
10.2 Southeast Asia IBS-C Drugs Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global IBS-C Drugs Market Size (Value) by Regions (2017-2022)
  11.1.1 United States IBS-C Drugs Revenue and Growth Rate (2017-2022)
  11.1.2 EU IBS-C Drugs Revenue and Growth Rate (2017-2022)
  11.1.3 Japan IBS-C Drugs Revenue and Growth Rate (2017-2022)
  11.1.4 China IBS-C Drugs Revenue and Growth Rate (2017-2022)
  11.1.5 India IBS-C Drugs Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia IBS-C Drugs Revenue and Growth Rate (2017-2022)
11.2 Global IBS-C Drugs Market Size (Value) by Type (2017-2022)
11.3 Global IBS-C Drugs Market Size by Application (2017-2022)

12 IBS-C DRUGS MARKET DYNAMICS

12.1 IBS-C Drugs Market Opportunities
12.2 IBS-C Drugs Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 IBS-C Drugs Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 IBS-C Drugs Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure IBS-C Drugs Product Scope
Figure Global IBS-C Drugs Market Size (Million USD) (2012-2017)
Table Global IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global IBS-C Drugs Market Share by Regions in 2016
Figure United States IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global IBS-C Drugs Market Share by Type in 2016
Figure Linaclotide Market Size (Million USD) and Growth Rate (2012-2017)
Figure Lubiprostone Market Size (Million USD) and Growth Rate (2012-2017)
Figure Osmotic Laxatives Market Size (Million USD) and Growth Rate (2012-2017)
Figure Stimulant Laxatives Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global IBS-C Drugs Market Share by Application in 2016
Table Key Downstream Customer in Hospital Pharmacies
Figure IBS-C Drugs Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2012-2017)
Table Key Downstream Customer in Retail Pharmacies
Figure IBS-C Drugs Market Size (Million USD) and Growth Rate in Retail Pharmacies (2012-2017)
Table Key Downstream Customer in Online Pharmacies
Figure IBS-C Drugs Market Size (Million USD) and Growth Rate in Online Pharmacies (2012-2017)
Table IBS-C Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure IBS-C Drugs Market Size Share by Players in 2016
Figure IBS-C Drugs Market Size Share by Players in 2017
Table Catalent Pharmaceuticals Solutions Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Catalent Pharmaceuticals Solutions (2012-2017)
Figure Catalent Pharmaceuticals Solutions IBS-C Drugs Business Revenue Market Share in 2016
Table Nestle Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Nestle (2012-2017)
Figure Nestle IBS-C Drugs Business Revenue Market Share in 2016
Table Abbott Laboratories Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Abbott Laboratories (2012-2017)
Figure Abbott Laboratories IBS-C Drugs Business Revenue Market Share in 2016
Table Synergy Pharmaceuticals Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Synergy Pharmaceuticals (2012-2017)
Figure Synergy Pharmaceuticals IBS-C Drugs Business Revenue Market Share in 2016
Table Sucampo Pharmaceuticals Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Sucampo Pharmaceuticals (2012-2017)
Figure Sucampo Pharmaceuticals IBS-C Drugs Business Revenue Market Share in 2016
Table Novartis Pharma Ag Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Novartis Pharma Ag (2012-2017)
Figure Novartis Pharma Ag IBS-C Drugs Business Revenue Market Share in 2016
Table Astellas Pharmaceuticals Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Astellas Pharmaceuticals (2012-2017)
Figure Astellas Pharmaceuticals IBS-C Drugs Business Revenue Market Share in 2016
Table Ardelyx, Inc Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Ardelyx, Inc (2012-2017)
Figure Ardelyx, Inc IBS-C Drugs Business Revenue Market Share in 2016
Table Synthetic Biologics, Inc Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Synthetic Biologics, Inc (2012-2017)
Figure Synthetic Biologics, Inc IBS-C Drugs Business Revenue Market Share in 2016
Table Teva Pharmaceutical Industries Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Teva Pharmaceutical Industries (2012-2017)
Figure Teva Pharmaceutical Industries IBS-C Drugs Business Revenue Market Share in 2016
Table Bama-Geve, SLU Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Bama-Geve, SLU (2012-2017)
Figure Bama-Geve, SLU IBS-C Drugs Business Revenue Market Share in 2016
Table Ferring BV Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Ferring BV (2012-2017)
Figure Ferring BV IBS-C Drugs Business Revenue Market Share in 2016
Table Ironwood Pharmaceuticals, Inc Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Ironwood Pharmaceuticals, Inc (2012-2017)
Figure Ironwood Pharmaceuticals, Inc IBS-C Drugs Business Revenue Market Share in 2016
Table Salix Pharmaceuticals Ltd Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Salix Pharmaceuticals Ltd (2012-2017)
Figure Salix Pharmaceuticals Ltd IBS-C Drugs Business Revenue Market Share in 2016
Table Norgine B.V Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Norgine B.V (2012-2017)
Figure Norgine B.V IBS-C Drugs Business Revenue Market Share in 2016
Table Prometheus Laboratories Inc Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Prometheus Laboratories Inc (2012-2017)
Figure Prometheus Laboratories Inc IBS-C Drugs Business Revenue Market Share in 2016
Table Actavis Nordic A/S Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Actavis Nordic A/S (2012-2017)
Figure Actavis Nordic A/S IBS-C Drugs Business Revenue Market Share in 2016
Table Albireo Pharma Inc Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Albireo Pharma Inc (2012-2017)
Figure Albireo Pharma Inc IBS-C Drugs Business Revenue Market Share in 2016
Table Yuhan Corp Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Yuhan Corp (2012-2017)
Figure Yuhan Corp IBS-C Drugs Business Revenue Market Share in 2016
Table Astrazeneca Plc Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Astrazeneca Plc (2012-2017)
Figure Astrazeneca Plc IBS-C Drugs Business Revenue Market Share in 2016
Table The Menarini Group Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of The Menarini Group (2012-2017)
Figure The Menarini Group IBS-C Drugs Business Revenue Market Share in 2016
Table Ono Pharmaceutical Co., Ltd Basic Information List
Table IBS-C Drugs Business Revenue (Million USD) of Ono Pharmaceutical Co., Ltd (2012-2017)
Figure Ono Pharmaceutical Co., Ltd IBS-C Drugs Business Revenue Market Share in 2016
Table Global IBS-C Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global IBS-C Drugs Market Size Share by Type in 2012
Figure Global IBS-C Drugs Market Size Share by Type in 2013
Figure Global IBS-C Drugs Market Size Share by Type in 2014
Figure Global IBS-C Drugs Market Size Share by Type in 2015
Figure Global IBS-C Drugs Market Size Share by Type in 2016
Figure Global IBS-C Drugs Market Size Share by Type in 2017
Table Global IBS-C Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global IBS-C Drugs Market Size (Million USD) by Application in 2012
Figure Global IBS-C Drugs Market Size (Million USD) by Application in 2013
Figure Global IBS-C Drugs Market Size (Million USD) by Application in 2014
Figure Global IBS-C Drugs Market Size (Million USD) by Application in 2015
Figure Global IBS-C Drugs Market Size (Million USD) by Application in 2016
Figure Global IBS-C Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of IBS-C Drugs
Figure United States IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States IBS-C Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States IBS-C Drugs Market Size Share by Players in 2016
Figure United States IBS-C Drugs Market Size Share by Players in 2017
Figure EU IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU IBS-C Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU IBS-C Drugs Market Size Share by Players in 2016
Figure EU IBS-C Drugs Market Size Share by Players in 2017
Figure Japan IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan IBS-C Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan IBS-C Drugs Market Size Share by Players in 2016
Figure Japan IBS-C Drugs Market Size Share by Players in 2017
Figure China IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China IBS-C Drugs Market Size (Million USD) by Players (2012-2017)
Figure China IBS-C Drugs Market Size Share by Players in 2016
Figure China IBS-C Drugs Market Size Share by Players in 2017
Figure India IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India IBS-C Drugs Market Size (Million USD) by Players (2012-2017)
Figure India IBS-C Drugs Market Size Share by Players in 2016
Figure India IBS-C Drugs Market Size Share by Players in 2017
Figure Southeast Asia IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia IBS-C Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia IBS-C Drugs Market Size Share by Players in 2016
Figure Southeast Asia IBS-C Drugs Market Size Share by Players in 2017
Figure Global IBS-C Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global IBS-C Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global IBS-C Drugs Market Size Share by Regions in 2017
Figure Global IBS-C Drugs Market Size Share by Regions in 2022
Figure United States IBS-C Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU IBS-C Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan IBS-C Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China IBS-C Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India IBS-C Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia IBS-C Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global IBS-C Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global IBS-C Drugs Market Size Share by Type in 2017
Figure Global IBS-C Drugs Market Size Share by Type in 2022
Table Global IBS-C Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global IBS-C Drugs Market Size (Million USD) by Application in 2017
Figure Global IBS-C Drugs Market Size (Million USD) by Application in 2022